HomeInsightsPB

Concord Drugs Ltd PB Ratio

Concord Drugs Ltd PB Ratio

stocks purchased

₹ 0.0 Cr

Volume Transacted

(Nov 13, 2024)

stocks purchased

1.6 K

Stocks Traded

(Nov 13, 2024)

Last Updated on: Nov 14, 2024

Image

Concord Drugs Ltd

NSE: CONCORDDRUGS

PB

1

Last updated on: Nov 13, 2024

Key Highlights

  • The P/B Ratio of Concord Drugs Ltd is 1 as of 13 Nov 24.
  • The P/B Ratio of Concord Drugs Ltd changed from 0.9 on March 2022 to 1 on March 2024 . This represents a CAGR of 3.57% over 3 years. .

Historical P/B Ratio of Concord Drugs Ltd

No data available

Company Fundamentals for Concord Drugs Ltd

Market Cap

34 Cr

EPS

0.0

P/E Ratio (TTM) *

0.0

P/B Ratio (TTM) *

1.0

Day’s High *

36.45

Day’s Low

34.57

DTE *

0.6

ROE *

-1.5

52 Week High

61.5

52 Week Low

30.59

ROCE *

2.3

Market Price Over Time

1M

1Y

3Y

5Y

Monitoring Concord Drugs Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
13 Nov 202434.76
12 Nov 202436.87
11 Nov 202437.41
08 Nov 202437.53
07 Nov 202438.58
06 Nov 202438.14
05 Nov 202438.11
04 Nov 202437.75
01 Nov 202438
31 Oct 202437.61

BlinkX Score for Concord Drugs Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Concord Drugs Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/B Ratio

Company NamePBMarket Cap (INR Cr.)
Concord Drugs Ltd134
Sun Pharmaceuticals Industries Ltd984,26,914
Divis Laboratories Ltd5131,53,258
Cipla Ltd3601,21,563
Torrent Pharmaceuticals Ltd2221,05,673
Dr Reddys Laboratories Ltd3221,03,939

Key Valuation Metric of Concord Drugs Ltd

Share Price

₹35

PB Ratio

The price-to-book (P/B) ratio compares a company's market capitalization to its book value by dividing its stock price per share by its book value per share.


How to calculate Price-to-Book (P/B) Ratio?

The Price-to-Book Ratio is used to determine the relationship between the total value of a company's outstanding shares and the net value of its assets. Before calculating the P/B ratio, investors need to overlook the market capitalization of a company.


Market capitalization = market value of a stock X no. of outstanding shares


Now, you need to know the net value of an organization's assets.

Book Value of Assets = Total Assets - Total Liabilities of a company


After knowing the value of the above ratios, here is the formula for the P/B Ratio:

P/B Ratio = Market Capitalization/ Book Value of Assets


or you can also use this formula

P/B ratio = Market Price Per Share/ Book Value of Asset Per Share

Historical Market Cap of Concord Drugs Ltd

No data available

* All values are in crore

Historical Revenue of Concord Drugs Ltd

No data available

* All values are in crore

Historical EBITDA of Concord Drugs Ltd

No data available

* All values are in crore

Historical Net Profit of Concord Drugs Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Concord Drugs Ltd News Hub

News

Concord Drugs announces board meeting date

Concord Drugs will hold a meeting of the Board of Directors of the Company on 13 November ...

Read more

08 Nov 202412:33

News

Concord Drugs to conduct AGM

Concord Drugs announced that the Annual General Meeting (AGM) of the company will be held ...

Read more

19 Sep 202417:57

News

Concord Drugs schedules AGM

Concord Drugs announced that the Annual General Meeting (AGM) of the company will be held ...

Read more

19 Sep 202410:06

News

Concord Drugs fixes board meeting date

Concord Drugs will hold a meeting of the Board of Directors of the Company on 6 September ...

Read more

03 Sep 202411:10

News

Concord Drugs to table results

Concord Drugs will hold a meeting of the Board of Directors of the Company on 9 August 202...

Read more

06 Aug 202416:20

News

Concord Drugs postpones board meeting

Concord Drugs has postponed the meeting of the Board of Directors which was scheduled to b...

Read more

25 May 202411:26

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PB Ratio of Concord Drugs Ltd

What is the PB ratio of Concord Drugs Ltd?

The current PB ratio of Concord Drugs Ltd is 1.03. The Price-to-Book value (P/B) ratio compares a company's current share price to its book value per share. It helps assess whether a stock is overvalued or undervalued relative to its net asset value.

What is the ideal PB ratio to buy Concord Drugs Ltd stocks?

An ideal PB ratio varies by industry; however, a PB ratio below 1.0 may indicate a good buying opportunity for Concord Drugs Ltd. Some investors and financial analysts may also consider any value under 3.0 as a good PB ratio.

How is the PB Ratio of Concord Drugs Ltd calculated?

The PB ratio of Concord Drugs Ltd is calculated by dividing the current share price by the book value per share. The book value per share is determined by dividing the company’s total net assets (assets minus liabilities) by the number of outstanding shares. This ratio helps evaluate how the market values the company's assets.

What does a high PB Ratio mean for Concord Drugs Ltd?

A high PB ratio suggests that Concord Drugs Ltd’s stock may be overvalued relative to its book value or that investors expect high growth.

What does a low PB Ratio indicate for Concord Drugs Ltd?

A low PB ratio of Concord Drugs Ltd may indicate that the stock is undervalued or it is facing financial difficulties.

Can Concord Drugs Ltd PB Ratio change over time?

Yes, the PB ratio of Concord Drugs Ltd can change over time due to fluctuations in the company’s stock price and changes in its book value.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*